SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Rockwell Medical, Inc. (RMTI)

Mar 01, 2016, 15:19 ET from Bronstein, Gewirtz & Grossman, LLC

NEW YORK, March 1, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Rockwell Medical, Inc. ("Rockwell" or "the Company") (NASDAQ: RMTI). Such investors are advised to contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz at info@bgandg.com or 212-697-6484.

This investigation concerns whether Rockwell Medical and certain of its officers and/or directors have violated the Federal Securities Laws under the Securities Exchange Act of 1934 (the "Exchange Act"). 

On September 9, 2015, Rockwell Medical released the U.S. commercial launch of Triferic, its new FDA approved iron product designed to replace iron and maintain hemoglobin in hemodialysis patients in the United States. On February 29, 2016, Rockwell Medical's CFO Tom Klema admitted to investors on a conference call after the market closed that sales of Triferic were "immaterial" for 2015, it managed to "sell" the kidney dialysis product Triferic for the last four months of 2015 without actually selling any of the product.

Following this news, Rockwell Medical stock dropped as much as $3.00 or 31.21% during intraday trading on March 1, 2016.

If you are aware of any facts relating to this investigation, or purchased shares of Rockwell, you can assist this investigation by visiting the firm's website: http://www.bgandg.com/#!rmti/xqi5h.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

 

SOURCE Bronstein, Gewirtz & Grossman, LLC



RELATED LINKS

http://www.bgandg.com